US Broker Ratings

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unpacking a 37.44% Potential Upside

Investors eyeing the healthcare sector might find ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) an intriguing opportunity, especially given its promising potential upside of 37.44%. As a player in the drug manufacturing..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 158.88% Upside in Diagnostics & Research

Opko Health, Inc. (NASDAQ: OPK) is making waves in the healthcare sector, particularly for those investors with an eye on the diagnostics and research industry. With a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Potential Amidst a 52-Week High

10x Genomics, Inc. (NASDAQ: TXG) is capturing investor attention as the company’s stock sits at the upper end of its 52-week range, recently hitting $79.10. This medical devices firm, based..

Omnicell, Inc. (OMCL) Stock Analysis: Robust Growth Potential with 78% Upside

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, is making waves with an impressive potential upside of 78.41% according to analysts. With a market cap of..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Diagnostic Sector with a 25.7% Revenue Growth Trajectory

GRAIL, Inc. (NASDAQ: GRAL), a key player in the healthcare sector, is making significant strides with its innovative approach to cancer diagnostics and research. With a market capitalization of $4.82..

Viridian Therapeutics, Inc. (VRDN): Biotechnology Stock with a 69.72% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has captured the attention of investors in the biotechnology sector with its robust pipeline and substantial growth potential. With a current market capitalization of $2.44..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 26.76% Potential Upside in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG) presents an intriguing proposition for investors looking to capitalize on the healthcare sector’s growth, particularly within the niche of medical care facilities. With a..

Evotec SE (EVO) Stock Analysis: Exploring a 176% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the dynamic healthcare sector, Evotec SE (EVO) presents a compelling case. Headquartered in Hamburg, Germany, Evotec SE operates as a drug discovery and development company,..

Alvotech (ALVO) Stock Analysis: A 15.65% Potential Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based company specializing in the development and manufacturing of biosimilar medicines, presents an intriguing opportunity for investors in the healthcare sector. Despite the current challenges in its..

PGIM Securitized Income ETF (PINC): A Stable Investment Amidst Volatile Markets?

Investors seeking stability in the unpredictable world of securities might find the PGIM Securitized Income ETF (NYSE: PINC) a compelling option. With a market capitalization of $4.08 billion, this fund..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a Biotech with a 187% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the healthcare sector with its innovative approach to addressing chronic diseases through oral small molecule therapeutics. With a market capitalization of..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 38.96% Potential Upside in the Healthcare SaaS Sector

Phreesia, Inc. (PHR), a key player in the healthcare industry, is garnering significant attention from investors due to its promising growth potential and strategic positioning within the SaaS-based software and..

Janux Therapeutics, Inc. (JANX): Investor Outlook with a Promising 113% Upside Potential

Janux Therapeutics, Inc. (NASDAQ: JANX) is drawing considerable attention in the biotechnology sector, not just due to its innovative approach to cancer treatment but also because of its significant potential..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 78% Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a notable player in the healthcare sector’s medical devices industry, has caught the attention of investors with its compelling growth potential. Headquartered in Kennesaw, Georgia, this..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 62% Upside Potential

Privia Health Group, Inc. (PRVA), a prominent player in the healthcare sector, is gaining attention from investors due to its potential for significant upside. Currently trading at $19.54, the stock..

Mesoblast Limited (MESO) Stock Analysis: A Deep Dive into its 139% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, stands at the forefront of regenerative medicine with its proprietary technology platform centered around mesenchymal lineage cells. As the healthcare sector continues..

Celldex Therapeutics (CLDX) Stock Analysis: A Biotech with a 55.9% Potential Upside and 14 Buy Ratings

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company renowned for developing therapeutic antibodies, is making waves in the biotechnology sector. With a market capitalization of $2.98 billion, this company has..

AdaptHealth Corp. (AHCO) Stock Analysis: Can a 56% Upside Offset Current Challenges?

AdaptHealth Corp. (NASDAQ: AHCO) appears to be a company worth watching closely, especially given the potential 56.52% upside as suggested by analyst target prices. This intriguing figure is set against..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 117% Upside Potential in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) is capturing significant attention in the biotechnology sector, with a market cap of $3.2 billion and an enticing potential upside of 117.29%, as projected by..

Novavax, Inc. (NVAX) Stock Analysis: Navigating a Potential 34.51% Upside Amidst Volatility

Novavax, Inc. (NASDAQ: NVAX), a key player in the biotechnology sector, is capturing investor attention with a potential upside of 34.51%. This potential, combined with its strategic partnerships and innovative..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds